The $85 million Iovance Cell Therapy Center (ICTC) has opened its doors at the Philadelphia Navy Yard with capacity to supply thousands of patients per year. Iovance celebrated the opening of its 136,000 square-foot commercial-scale production facility, commissioned in 2018 at a cost of around $85 million, this week. “Since Iovance was founded, we have been dedicated to advancing novel cell therapies for patients with solid tumor cancers,†Iovance CEO Frederick Vogt said. “A little over two years after breaking…
